New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 13, 2014
14:35 EDTACT, MNKActavis' generic version of Exalgo approved by FDA
The FDA approved Actavisí (ACT) generic version of hydromorphone hydrochloride in strengths of 8 mg, 12 mg and 16 mg on May 12, according to a post to the FDA website. Hydromorphone hydrochloride is sold in branded form under the name Exalgo by Mallinckrodt (MNK). Reference Link
News For MNK;ACT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
August 31, 2015
15:32 EDTMNKViking Global reports 4.9% passive stake in Mallinckrodt
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use